Trials / Completed
CompletedNCT03003507
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients: A Cross-over Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Hospital Moinhos de Vento · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Hyperglycemia is a known risk factor for mortality in critically ill patients. Most of these patients receive enteral feeding. There is controversy about ideal carbohydrate composition of these diets. The aim of this study was to compare an enteral formula with the same proportion of carbohydrates with and without fructose on blood glucose levels.
Detailed description
Randomized, cross-over, controlled, double-blind clinical trial without washout. Adult patients admitted to the ICU who presented capillary glycemia values\> 180mg / dl with a full and exclusive enteral diet. They were randomized and observed for 4 days (2 days with each diet: with / without fructose). Capillary glycemia was measured 4 / 4h.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Enteral Formula With Fructose | Low-carbohydrate Enteral Formula With Fructose |
| DIETARY_SUPPLEMENT | Enteral Formula Without Fructose | Low-carbohydrate Enteral Formula Without Fructose |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-04-01
- Completion
- 2013-04-01
- First posted
- 2016-12-28
- Last updated
- 2016-12-28
Source: ClinicalTrials.gov record NCT03003507. Inclusion in this directory is not an endorsement.